tiprankstipranks
Trending News
More News >
Relx PLC (ADR) (RELX)
NYSE:RELX

Relx (RELX) AI Stock Analysis

Compare
300 Followers

Top Page

RELX

Relx

(NYSE:RELX)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - 5.2)
Rating:69Neutral
Price Target:
$39.00
▼(-2.94% Downside)
Action:ReiteratedDate:02/18/26
Strong fundamentals (high margins and very strong cash generation) and a positive earnings outlook with substantial capital returns are the main supports. The score is held back by weak technicals (price below all major moving averages with negative momentum) and balance-sheet leverage/equity decline, while valuation is reasonable but not clearly cheap.
Positive Factors
Cash generation & conversion
Near-100% cash conversion and multi‑billion free cash flow are durable strengths: they fund dividends, large buybacks, capex and selective M&A while reducing reliance on external financing, supporting capital returns and reinvestment over the medium term.
High margins and sustained profitability
Consistently high gross and net margins reflect a content-and-analytics business with low incremental costs and recurring revenue. Margin durability supports cash flow resilience, ability to invest in product development and competitive pricing power over multiple quarters.
Content + AI competitive moat
Deep, curated data assets combined with embedded AI-driven workflows create high switching costs and differentiated offerings in Legal and Risk. This structural shift to analytics/SaaS increases recurring revenue and makes disruption by generic competitors harder over time.
Negative Factors
Elevated leverage and reduced equity
Material gross debt and higher debt-to-equity reduce financial flexibility and increase sensitivity to interest rates or macro shocks. With equity decline in 2025, the capital structure leaves less room for error and constrains the pace of inorganic investment.
Slowing top-line growth / mature market
A shift toward slower or slightly negative reported revenue indicates maturity and greater reliance on margin expansion or buybacks to drive EPS. Sustaining growth will require successful product-led adoption and conversion of large addressable but gradual markets.
Structural decline in print-related revenues
A multi-year secular decline in print revenue forces reallocation of resources to digital and analytics. Transition costs and portfolio drag can weigh on reported growth and create timing risk as new higher-value products scale over several years.

Relx (RELX) vs. SPDR S&P 500 ETF (SPY)

Relx Business Overview & Revenue Model

Company DescriptionRELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity. The Exhibitions segment is involved in the events business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and complete transactions. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.
How the Company Makes MoneyRELX primarily makes money by selling subscription and license access to specialized content, databases, and analytics platforms used by institutions and professionals, complemented by transactional revenues and event-related fees. 1) Subscription and licensing (largest driver across most segments): - STM (Elsevier): Generates revenue largely from multi-year subscriptions and licensing agreements with universities, research institutes, corporate R&D, and government customers for access to scientific journals, books, and research platforms. It also sells workflow and analytics tools that support research discovery, management, and evaluation, typically under recurring license or subscription models. - Legal (LexisNexis Legal & Professional): Earns revenue from recurring subscriptions to legal research databases and practice/analytics tools purchased by law firms, corporations, and public-sector legal organizations. Pricing is commonly seat-based or usage-tiered under term contracts. - Risk (LexisNexis Risk Solutions): Sells access to data assets and analytics delivered via platforms and APIs to banks, insurers, payments firms, telecoms, and public sector entities. Revenues are generated through recurring subscriptions and contracted services, as well as usage-based fees tied to transaction volumes (e.g., identity verification checks, fraud screening calls, risk scores). 2) Transactional and services revenue: - Risk: A meaningful portion can be usage/transaction-driven (per-search, per-transaction, or volume-based API pricing), where customer activity levels directly influence revenue. - Legal and STM: Additional revenue may come from one-time content purchases, document delivery, training, professional services, and certain database transactions (exact mix varies by product). 3) Author-facing and publishing-related revenues (STM): - Elsevier also earns from publishing-related fees associated with making research outputs available under specific distribution models (where applicable). If specific fee structures or proportions are not publicly detailed for a given product line, null. 4) Exhibitions (RX) revenue: - RX generates revenue by organizing and hosting B2B exhibitions and related digital offerings. Key revenue streams include exhibitor fees for booth space and sponsorships/marketing packages, as well as attendee registration fees for certain events. Revenue levels are influenced by the number and scale of events held, exhibitor demand, attendee participation, and event format (in-person, hybrid, digital). 5) Cross-segment monetization factors: - Data, content, and analytics are monetized through long-term customer relationships and high switching costs, as RELX products are embedded in customers’ workflows (research, compliance, underwriting, legal practice). - Platform delivery (cloud, SaaS, and APIs) supports recurring revenue and enables usage-based pricing, particularly in Risk. Partnerships and major customer channels: null

Relx Key Performance Indicators (KPIs)

Any
Any
Revenue by Segment
Revenue by Segment
Analyzes income from different business units, highlighting which segments are driving growth and which may need strategic adjustments.
Chart InsightsRelx's Risk segment is experiencing robust growth, with recent earnings highlighting an 8% increase in underlying revenue, driven by strategic focus on analytics and decision tools. The Scientific, Technical, and Medical segment shows volatility, but new product introductions are fostering a 5% revenue rise. Legal and Exhibitions segments are also performing well, with 9% and 8% revenue growth respectively, surpassing pre-pandemic margins. Despite challenges from declining print revenues and currency impacts, the company's strategic transition to digital and strong cash flow management underpin its positive outlook.
Data provided by:The Fly

Relx Earnings Call Summary

Earnings Call Date:Feb 12, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Jul 23, 2026
Earnings Call Sentiment Positive
The call conveyed a broadly positive performance: solid underlying revenue (7%), stronger operating profit (9%), EPS growth (10% constant currency), margin expansion (~90bps), strong cash generation and meaningful capital returns (dividend increase and large buyback). All four divisions grew (Risk, Legal, STM, Exhibitions) with notable AI-driven adoption in Legal and Risk and strong research submission trends in STM. Offsets include a material reduction in print-related revenue (>20%), portfolio effects and currency headwinds that restrained reported sterling growth, selective (below-average) M&A activity, and some timing/competitive risks in new product rollouts and workflow competition. On balance the positives substantially outweigh the negatives.
Q4-2025 Updates
Positive Updates
Strong Group Financial Performance
Underlying revenue growth 7%; underlying adjusted operating profit growth 9%; adjusted earnings per share up 10% at constant currency (128.5p, +7% in sterling). Group adjusted operating margin improved by ~90 basis points to 34.8%.
Robust Cash Generation and Capital Return
Cash conversion 99%; EBITDA > GBP 3.8bn; capital expenditure GBP 525m (5% of revenue); free cash flow > GBP 2.3bn. Completed GBP 1.5bn buyback in 2025 and announced GBP 2.25bn buyback for 2026 (GBP 250m already deployed); dividend increased 7% to 67.5p.
Risk: High Growth and Deep AI Integration
Risk underlying revenue growth 8% and underlying adjusted operating profit growth 10%. Over 90% of divisional revenue from machine-to-machine interactions driven by embedded AI-enabled analytics and decision tools.
STM Momentum and Scientific Volume Growth
STM underlying revenue growth 5% and underlying adjusted operating profit growth 7%. Primary Research submissions grew over 20% in 2025 and published articles grew 10%; new higher-value products (e.g., LeapSpace) launched with positive early signals.
Legal: AI Adoption and Strong Profitability
Legal underlying revenue growth 9% and underlying adjusted operating profit growth 12%. Lexis+ AI enterprise-wide subscription base more than doubled in the past year with usage increasing faster; hundreds of thousands of users and continued roll-out of Protege AI workflows (approaching ~300 workflows).
Exhibitions: Revenue Recovery and Margin Expansion
Exhibitions underlying revenue growth 8% and underlying adjusted operating profit growth 9%. Margin expansion materially ahead of history (Exhibitions margin increase ~250 basis points) supported by portfolio improvements and digital initiatives.
Operational Leverage and Margin Upside
Cost growth managed below revenue growth across business areas; Risk, STM and Legal delivered profit growth 2–3 percentage points ahead of revenue growth; management expects adjusted operating profit growth to continue to exceed revenue growth going forward.
Strategic Positioning Around Content + AI
Clear strategic emphasis on shifting mix toward higher-growth analytics and decision tools, embedding AI across products, leveraging unique, curated content and contributory databases to create differentiated, hard-to-replicate offerings.
Negative Updates
Print and Print-Related Revenue Decline
Proactive reduction in print-related activities led to a reduction in associated revenue of over 20%. Profit from print and print-related activities declined and is expected to continue to decline in the high single digits annually.
Portfolio Effects and Revenue Drag
After portfolio effects and the print step-down, total group revenue growth at constant currency was 4% (versus 7% underlying); in sterling total revenue growth was 2% — portfolio moves and print decline were a slight drag on reported growth.
Currency Headwinds
Strong pound versus dollar impacted sterling-reported results: adjusted operating profit growth in sterling was 4% (vs. higher constant-currency metrics) and adjusted EPS growth in sterling was +7% (vs +10% at constant currency).
M&A Spend Below Long-Term Average
Acquisition spend in 2025 was GBP 270m versus a 10-year average of ~GBP 400m per year; management notes M&A is selective and organic development remains the priority, which may limit near-term inorganic acceleration.
Gradual Adoption and Timing Risk in Some New Markets
STM corporate opportunity and some new product monetization are important but currently small and expected to scale gradually (institutional addressable market rollout likely to be multi-year), creating timing risk to near-term upside.
Competitive and Market Uncertainty around Workflow Tools
Questions from investors about potential incursion by large software/AI workflow competitors in Legal and broader market volatility were raised; management maintains confidence in content moat but competitive dynamics and broader market sentiment represent execution risks.
Company Guidance
Management guidance is for continued strong underlying revenue growth across the Group, with underlying adjusted operating profit growth ahead of revenue and strong adjusted EPS growth on a constant‑currency basis; divisional guidance was consistent with that view (Risk: sustain strong long‑term growth — FY25 underlying revenue +8% and underlying adjusted operating profit +10%; STM: “good to strong” revenue growth — FY25 revenue +5% and op profit +7%; Legal: continued strong revenue growth — FY25 revenue +9% and op profit +12%; Exhibitions: continued strong revenue growth and an improvement in adjusted operating margin — FY25 revenue +8% and op profit +9%, margin +250bps). They reiterated CapEx around 5% of revenue (FY25 CapEx £525m), organic development as top priority, selective M&A (FY25 acquisitions £270m; 10‑year average c.£400m p.a.), dividend up 7% to 67.5p, a £2.25bn buyback for 2026 (£250m deployed), targeted leverage 2.0–2.5x (year‑end 2025 net debt £7.2bn, net debt/EBITDA 2.0x), cash conversion 99%, and an expectation that print‑related profit will continue to decline in the high single digits annually.

Relx Financial Statement Overview

Summary
High-quality profitability and cash generation (stable ~64–65% gross margin, ~19–21% net margin, strong FCF and ~99% cash conversion) support a strong operating profile. Offsetting factors are slower/negative reported revenue in 2025 and a more leveraged balance sheet with equity decline, which reduces flexibility.
Income Statement
78
Positive
RELX shows consistently strong profitability: gross margin has held around ~64–65% (2020–2024) and net margin has stayed near ~19–21% (2021–2024). Earnings have generally trended up from 2020–2024, and operating profitability remains solid. The key weakness is growth: revenue growth slowed materially and turned slightly negative in 2025 (annual revenue down ~1.6% vs. 2024), suggesting a more mature top-line profile and potential sensitivity to demand softness.
Balance Sheet
58
Neutral
Leverage is the main constraint. Debt has stayed high (roughly £6.5–£7.3B), and debt relative to equity is elevated (about ~1.8–1.9x in 2021–2024, with a much higher level in 2020). Equity also declined notably in 2025 versus 2024, which reduces balance sheet flexibility. Offsetting this, the business generates strong profits relative to equity (high returns on equity in 2021–2024), indicating efficient capital use—but the capital structure leaves less room for error if conditions weaken.
Cash Flow
86
Very Positive
Cash generation is a clear strength. Operating cash flow and free cash flow have been consistently strong, with free cash flow rising meaningfully from 2023 to 2024 and remaining very high in 2025. Cash conversion is solid: free cash flow was close to net income in 2024 (roughly ~99%), supporting funding capacity for dividends, buybacks, or debt management. The main weakness is some variability over time (notably weaker free-cash-flow growth in 2020 and more modest improvement in 2023), but overall cash flow quality is strong.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue9.38B9.43B9.16B8.55B7.24B
Gross Profit5.98B6.13B5.95B5.51B4.68B
EBITDA3.72B3.13B3.31B3.06B2.65B
Net Income2.02B1.93B1.78B1.63B1.47B
Balance Sheet
Total Assets14.73B15.13B14.92B15.83B13.86B
Cash, Cash Equivalents and Short-Term Investments130.77M119.00M155.00M334.00M113.00M
Total Debt7.32B6.54B6.50B6.73B6.17B
Total Liabilities12.35B11.63B11.48B12.07B10.63B
Stockholders Equity2.36B3.48B3.46B3.78B3.23B
Cash Flow
Free Cash Flow2.79B2.59B1.98B1.97B1.68B
Operating Cash Flow2.81B2.61B2.46B2.40B2.02B
Investing Cash Flow-810.83M-575.00M-569.00M-859.00M-384.00M
Financing Cash Flow-1.99B-2.06B-2.06B-1.33B-1.61B

Relx Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price40.18
Price Trends
50DMA
36.14
Negative
100DMA
39.17
Negative
200DMA
44.61
Negative
Market Momentum
MACD
0.18
Negative
RSI
55.89
Neutral
STOCH
88.02
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RELX, the sentiment is Neutral. The current price of 40.18 is above the 20-day moving average (MA) of 32.46, above the 50-day MA of 36.14, and below the 200-day MA of 44.61, indicating a neutral trend. The MACD of 0.18 indicates Negative momentum. The RSI at 55.89 is Neutral, neither overbought nor oversold. The STOCH value of 88.02 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for RELX.

Relx Risk Analysis

Relx disclosed 17 risk factors in its most recent earnings report. Relx reported the most risks in the "Tech & Innovation" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Relx Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$13.03B32.9317.55%0.95%8.43%21.38%
70
Outperform
$1.93B13.7420.75%4.48%-5.33%
69
Neutral
$63.40B27.2590.85%2.00%5.32%6.06%
65
Neutral
$872.90M3.37-0.37%2.78%2.53%-23.86%
64
Neutral
$8.21B20.718.86%2.11%1.93%34.40%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
RELX
Relx
35.19
-11.23
-24.20%
WLY
John Wiley Sons Cl A
36.61
-8.38
-18.63%
NYT
New York Times
78.83
30.68
63.73%
PSO
Pearson
13.09
-3.03
-18.81%
SCHL
Scholastic
34.31
14.06
69.47%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 18, 2026